{"id":4012,"date":"2023-06-10T20:51:57","date_gmt":"2023-06-10T20:51:57","guid":{"rendered":"https:\/\/healthnews.zone\/?p=4012"},"modified":"2023-06-10T20:51:58","modified_gmt":"2023-06-10T20:51:58","slug":"how-new-technologies-are-changing-the-future-of-ms-treatments","status":"publish","type":"post","link":"https:\/\/healthnews.zone\/?p=4012","title":{"rendered":"How New Technologies Are Changing the Future of MS Treatments"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img decoding=\"async\" src=\"data:image\/svg+xml,%3Csvg%20xmlns='http:\/\/www.w3.org\/2000\/svg'%20viewBox='0%200%20370%20247'%3E%3C\/svg%3E\" data-lazy-src=\"https:\/\/healthnews.zone\/wp-content\/uploads\/2023\/06\/image-80-1024x576.png\" alt=\"\" class=\"zeen-lazy-load-base zeen-lazy-load wp-image-4013\"\/><noscript><img decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/healthnews.zone\/wp-content\/uploads\/2023\/06\/image-80-1024x576.png\" alt=\"\" class=\"wp-image-4013\" srcset=\"https:\/\/healthnews.zone\/wp-content\/uploads\/2023\/06\/image-80-1024x576.png 1024w, https:\/\/healthnews.zone\/wp-content\/uploads\/2023\/06\/image-80-300x169.png 300w, https:\/\/healthnews.zone\/wp-content\/uploads\/2023\/06\/image-80-770x433.png 770w, https:\/\/healthnews.zone\/wp-content\/uploads\/2023\/06\/image-80-293x165.png 293w, https:\/\/healthnews.zone\/wp-content\/uploads\/2023\/06\/image-80-390x219.png 390w, https:\/\/healthnews.zone\/wp-content\/uploads\/2023\/06\/image-80.png 1110w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/noscript><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">In 1993, interferon beta-1b made history as the first drug to ever be approved for\u00a0<a href=\"https:\/\/www.everydayhealth.com\/multiple-sclerosis\/guide\/\">multiple sclerosis (MS)<\/a>. It also happens to be the year that Nancy Davis founded\u00a0<a rel=\"noreferrer noopener\" href=\"https:\/\/www.erasems.org\/\" target=\"_blank\">Race to Erase MS<\/a>, an organization dedicated to funding cutting-edge, aggressive, and promising research in pursuit of a cure. To date, the organization has raised over $50 million for\u00a0<a href=\"https:\/\/www.everydayhealth.com\/multiple-sclerosis\/guide\/resources\/\">multiple sclerosis research<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read more: <a href=\"https:\/\/www.everydayhealth.com\/multiple-sclerosis\/how-new-technologies-are-changing-the-future-of-ms-treatments\/\">https:\/\/www.everydayhealth.com\/multiple-sclerosis\/how-new-technologies-are-changing-the-future-of-ms-treatments\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In 1993, interferon beta-1b made history as the first drug to ever be approved for\u00a0multiple sclerosis (MS). It also happens to be the year that Nancy Davis founded\u00a0Race to Erase MS, an organization dedicated to funding cutting-edge, aggressive, and promising research in pursuit of a cure. To date, the organization has raised over $50 million for\u00a0multiple sclerosis research. Read more: https:\/\/www.everydayhealth.com\/multiple-sclerosis\/how-new-technologies-are-changing-the-future-of-ms-treatments\/<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-4012","post","type-post","status-publish","format-standard","hentry","category-conditions"],"_links":{"self":[{"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/posts\/4012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/healthnews.zone\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4012"}],"version-history":[{"count":1,"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/posts\/4012\/revisions"}],"predecessor-version":[{"id":4014,"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/posts\/4012\/revisions\/4014"}],"wp:attachment":[{"href":"https:\/\/healthnews.zone\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/healthnews.zone\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/healthnews.zone\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}